ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Galiximab in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma

ClinicalTrials.gov ID: NCT00516217

Public ClinicalTrials.gov record NCT00516217. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Study of Galiximab (Anti-CD80) for Patients With Relapsed/Refractory Hodgkin Lymphoma

Study identification

NCT ID
NCT00516217
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Alliance for Clinical Trials in Oncology
Other
Enrollment
30 participants

Conditions and interventions

Conditions

Interventions

  • galiximab Biological

Biological

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2008
Primary completion
Aug 31, 2011
Completion
Jan 31, 2015
Last update posted
Jul 5, 2016

2008 – 2015

United States locations

U.S. sites
56
U.S. states
15
U.S. cities
42
Facility City State ZIP Site status
Tunnell Cancer Center at Beebe Medical Center Lewes Delaware 19958
CCOP - Christiana Care Health Services Newark Delaware 19713
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington D.C. District of Columbia 20007
St. Joseph Medical Center Bloomington Illinois 61701
Graham Hospital Canton Illinois 61520
Memorial Hospital Carthage Illinois 62321
University of Chicago Cancer Research Center Chicago Illinois 60637-1470
Eureka Community Hospital Eureka Illinois 61530
Galesburg Clinic, PC Galesburg Illinois 61401
Galesburg Cottage Hospital Galesburg Illinois 61401
Mason District Hospital Havana Illinois 62644
Hopedale Medical Complex Hopedale Illinois 61747
McDonough District Hospital Macomb Illinois 61455
BroMenn Regional Medical Center Normal Illinois 61761
Community Cancer Center Normal Illinois 61761
Community Hospital of Ottawa Ottawa Illinois 61350
Oncology Hematology Associates of Central Illinois, PC - Ottawa Ottawa Illinois 61350
Cancer Treatment Center at Pekin Hospital Pekin Illinois 61554
Proctor Hospital Peoria Illinois 61614
CCOP - Illinois Oncology Research Association Peoria Illinois 61615
Oncology Hematology Associates of Central Illinois, PC - Peoria Peoria Illinois 61615
Methodist Medical Center of Illinois Peoria Illinois 61636
OSF St. Francis Medical Center Peoria Illinois 61637
Illinois Valley Community Hospital Peru Illinois 61354
Perry Memorial Hospital Princeton Illinois 61356
St. Margaret's Hospital Spring Valley Illinois 61362
Elkhart General Hospital Elkhart Indiana 46515
Howard Community Hospital Kokomo Indiana 46904
Center for Cancer Therapy at LaPorte Hospital and Health Services La Porte Indiana 46350
CCOP - Northern Indiana CR Consortium South Bend Indiana 46601
Memorial Hospital of South Bend South Bend Indiana 46601
Saint Joseph Regional Medical Center South Bend Indiana 46617
South Bend Clinic South Bend Indiana 46617
CancerCare of Maine at Eastern Maine Medical Center Bangor Maine 04401
Union Hospital Cancer Program at Union Hospital Elkton MD Maryland 21921
Lakeland Regional Cancer Care Center - St. Joseph Saint Joseph Michigan 49085
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis St Louis Missouri 63110
Cancer Resource Center - Lincoln Lincoln Nebraska 68510
CCOP - Missouri Valley Cancer Consortium Omaha Nebraska 68106
Immanuel Medical Center Omaha Nebraska 68122
Alegant Health Cancer Center at Bergan Mercy Medical Center Omaha Nebraska 68124
Creighton University Medical Center Omaha Nebraska 68131-2197
Cancer Institute of New Jersey at Cooper - Voorhees Voorhees Township New Jersey 08043
New York Weill Cornell Cancer Center at Cornell University New York New York 10021
Mount Sinai Medical Center New York New York 10029
Randolph Hospital Asheboro North Carolina 27203-5400
Presbyterian Cancer Center at Presbyterian Hospital Charlotte North Carolina 28233-3549
Wayne Memorial Hospital, Incorporated Goldsboro North Carolina 27534
Moses Cone Regional Cancer Center at Wesley Long Community Hospital Greensboro North Carolina 27403-1198
Kinston Medical Specialists Kinston North Carolina 28501
Annie Penn Cancer Center Reidsville North Carolina 27320
Wake Forest University Comprehensive Cancer Center Winston-Salem North Carolina 27157-1096
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus Ohio 43210-1240
Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital Pittsburgh Pennsylvania 15224-1791
Danville Regional Medical Center Danville Virginia 24541
Virginia Commonwealth University Massey Cancer Center Richmond Virginia 23298-0037

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00516217, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 5, 2016 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00516217 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →